In last trading session, TG Therapeutics Inc (NASDAQ:TGTX) saw 2.84 million shares changing hands with its beta currently measuring 2.17. Company’s recent per share price level of $27.90 trading at $0.73 or 2.69% at ring of the bell on the day assigns it a market valuation of $4.32B. That closing price of TGTX’s stock is at a premium of 0.82% from its 52-week high price of $27.67 and is indicating a premium of 64.84% from its 52-week low price of $9.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.78 million shares which gives us an average trading volume of 3.62 million if we extend that period to 3-months.
For TG Therapeutics Inc (TGTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.09 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
TG Therapeutics Inc (NASDAQ:TGTX) trade information
Upright in the green during last session for gaining 2.69%, in the last five days TGTX remained trading in the green while hitting it’s week-highest on Thursday, 11/07/24 when the stock touched $27.90 price level, adding 1.8% to its value on the day. TG Therapeutics Inc’s shares saw a change of 63.35% in year-to-date performance and have moved 11.33% in past 5-day. TG Therapeutics Inc (NASDAQ:TGTX) showed a performance of 27.43% in past 30-days. Number of shares sold short was 32.48 million shares which calculate 7.76 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 23 to the stock, which implies a fall of -21.3% to its current value. Analysts have been projecting 16 as a low price target for the stock while placing it at a high target of 55. It follows that stock’s current price would jump 42.65% in reaching the projected high whereas dropping to the targeted low would mean a gain of 42.65% for stock’s current value.
TG Therapeutics Inc (TGTX) estimates and forecasts
Statistics highlight that TG Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 64.89% of value to its shares in past 6 months, showing an annual growth rate of 66.67% while that of industry is 11.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 40.60% from the last financial year’s standing.
8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 98.35M for the same. And 4 analysts are in estimates of company making revenue of 110.83M in the next quarter. Company posted 43.97M and 63.47M of sales in current and next quarters respectively a year earlier.
TG Therapeutics Inc (NASDAQ:TGTX)’s Major holders
Insiders are in possession of 9.59% of company’s total shares while institution are holding 61.91 percent of that, with stock having share float percentage of 68.48%. Investors also watch the number of corporate investors in a company very closely, which is 61.91% institutions for TG Therapeutics Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at TGTX for having 13.69 million shares of worth $243.58 million. And as of 2024-06-30, it was holding 9.3645 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 11.39 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.7891 of outstanding shares, having a total worth of $202.6 million.
